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Strengths and limitations of this study
 ► This study followed robust methodologies in accor-
dance with Core Outcome Measures in Effectiveness 
Trials-initiative guidelines.
 ► Two core outcome sets are produced for vision 
screening and for full assessment of stroke survi-
vors with visual impairment.
 ► There is potential for their use with other types of 
acquired brain injury causing visual impairment.
 ► Attrition rates were moderate but similar to other 
Delphi surveys.
 ► Larger response numbers, including international 
participants, would be of benefit.
AbStrACt
Objectives Visual impairment following stroke is common 
with a reported incidence of visual impairment in 60% of 
stroke survivors. Screening for visual impairment is neither 
routine nor standardised. This results in a health inequality 
where some stroke survivors receive comprehensive vision 
assessment to identify any existent visual problems while 
others receive no vision assessment leaving them with 
unmet needs from undiagnosed visual problems. The aim 
of this study was to define two core outcome sets (COS), 
one for vision screening and one for full visual assessment 
of stroke survivors.
Design A list of potentially relevant visual assessments 
was created from a review of the literature. The consensus 
process consisted of an online 3-round Delphi survey 
followed by a consensus meeting of the key stakeholders.
Participants Stakeholders included orthoptists, 
occupational therapists, ophthalmologists, stroke survivors 
and COS users such as researchers, journal editors and 
guideline developers.
Setting University.
Outcome measures COS.
results Following the consensus process we recommend 
the following nine assessments for vision screening: 
case history, clinical observations of visual signs, visual 
acuity, eye alignment position, eye movement assessment, 
visual field assessment, visual neglect assessment, 
functional vision assessment and reading assessment. We 
recommend the following 11 assessments for full vision 
assessment: case history, observations, visual acuity, eye 
alignment position, eye movement assessment, binocular 
vision assessment, eye position measurement, visual 
field assessment, visual neglect assessment, functional 
vision assessment, reading assessment and quality of life 
questionnaires.
Conclusions COS are defined for vision screening and full 
vision assessment for stroke survivors. There is potential 
for their use in reducing heterogeneity in routine clinical 
practice and for improving standardisation and accuracy of 
vision assessment. Future research is required to evaluate 
the use of these COS and for further exploration of core 
outcome measures.
IntrODuCtIOn
Visual impairment is common in stroke 
occurring in up to 73% of stroke survivors.1 
Visual impairment is typically categorised 
into impairments of central vision, eye 
movements, visual fields and visual percep-
tion.2 Vision is arguably our most important 
sense. Visual impairment results in impaired 
activities of daily living with reduced quality 
of life through loss of independence, greater 
risk of trips and falls and accidents.3–6 This 
leads to loss of independence and potentially 
results in social isolation and depression.5 6
The primary focus of stroke rehabilitation 
is often occupational therapy and physio-
therapy to mobilise patients, improve limb 
function and balance and engage in activi-
ties of daily living plus speech and language 
therapy for communication difficulties.7 
Many rehabilitation strategies require visual 
input, for example to safely mobilise around 
potential obstacles, recognise depth and posi-
tion of objects and recognise visual cue cards. 
Given so many stroke survivors have visual 
impairment it is important to screen for this 
at an early time point post-stroke onset with 
the aim to optimise the rehabilitation process.
The recent Impact of Visual Impairment 
after Stroke (IVIS) study reported specialist 
orthoptist vision screening is possible at a 
median of 3 days post-stroke onset with the 
majority of stroke survivors being assessed 
within 1 week of stroke onset.1 This study 
used standardised visual assessment methods 
with portable equipment to be used at the 
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patient’s bedside. There is, however, no standardised 
visual screening assessment for post-stroke visual impair-
ment. In one UK survey it was found that 45% of stroke 
services provided no formal vision assessment for stroke 
patients.8 A further survey of practice identified that only 
7% of stroke units had a policy relating to vision assess-
ment and management.9 Both surveys showed lack of 
standardisation for vision assessment and treatment for 
stroke survivors. The National Stroke Strategy argues that 
vision and visual perceptual difficulties are components 
requiring multifaceted stroke specific rehabilitation and 
support.10 The Royal College of Physicians recommend 
that every patient with stroke has a practical assessment of 
vision and examination of the visual field.11
On the basis that there is no consensus on how to 
adequately screen for visual impairment after brain injury, 
the aim of this study was to achieve consensus on the 
content of vision screening and full vision assessment for 
stroke survivors in order to better identify visual impair-
ment. Screening and/or full vision assessments are to be 
undertaken at any time point post-stroke onset with the 
intention that identification of visual impairment enables 
prompt access to earlier visual rehabilitation options. 
One approved process to reach consensus on screening 
and assessment for specific conditions is through the 
development of core outcome sets (COS).12 COS indicate 
the minimum that should be measured and reported in 
all studies of a specific condition. The overall purpose of 
a vision screening and full assessment COS is to improve 
routine care in the UK National Health Service (NHS) 
through standardisation of assessments.
In this study we report the results of a Delphi process 
and consensus meetings in the development of a COS 
for vision screening and a COS for full vision assessment 
of stroke survivors. Vision screening was defined as the 
assessments considered important for use by clinicians 
not working in eye care settings and without formal expe-
rience or training in performing eye tests. Full vision 
assessment was defined as the assessments considered 
important for use by clinicians who had formal eye care 
training and were principally based in eye clinics and 
providing more detailed assessment than possible with 
screening assessment of basic levels of visual function.
MethODS
ethical approval
Informed consent was obtained for the Delphi survey—
the participant checked a consent tick box on the 
opening page of the survey. Informed written consent was 
obtained from all participants in the consensus meeting.
Development of the COS involved three phases: (1) 
the generation of a comprehensive list of outcomes; (2) 
a Delphi survey involving three rounds to gain consensus 
as to which outcomes are most important; and (3) patient 
and professional consensus meetings to agree a final COS. 
A protocol for the development of this COS project was 
written by the steering committee, registered in the Core 
Outcome Measures in Effectiveness Trials (COMET) 
initiative website (http://www. comet- initiative. org/ 
studies/ details/ 275? result= true) and available as open 
access (http:// pcwww. liv. ac. uk/~ rowef/ index_ files/ 
Page356. html). When developing this COS, we followed 
the minimum set of development standards set out by 
Core Outcome Set-STAndards for Development State-
ment, and report the results against the Core Outcome 
Set–STAndards for Reporting guideline.13 14
Steering group
A steering group was set up to inform the development of 
the various stages of this study and to discuss the results 
at each phase of the study. It comprised a representative 
from clinical professions involved in the vision screening 
of patients with acute stroke brain injury (orthoptist, 
occupational therapist and neuro-ophthalmologist), two 
stroke survivors and COS users (clinical and academic 
researchers, systematic reviewer and clinical guideline 
developer); eight members in total. Clinicians were 
identified from a national orthoptist stroke clinical advi-
sory group, a regional allied health profession research 
network and regional ophthalmology research network. 
Stroke survivors were identified from a national stroke/
vision patient and public involvement panel. COS users 
were identified from local university staff with links to 
the COMET initiative and/or those involved in national 
clinical guideline panels. The COMET initiative brings 
together people interested in the development and appli-
cation of agreed standardised sets of outcomes (http://
www. comet- initiative. org/).
Patient and public involvement
The development of this research question was informed 
by patients’ priorities, experience and preferences 
outlined by a National Institute for Health Research 
James Lind Alliance priority setting partnership. Patients 
were involved in the design of this study as members of 
the steering group set up specifically for the study and 
outlined previously. Further, patients were involved in 
the recruitment to and conduct of the study through 
the VISable patient and public involvement panel which 
is described below in the next section. Results will be 
disseminated to study participants by emailing a copy 
of the full publication of this research along with a lay 
summary of the results.
Stakeholders
For participation in this study, we sought the input of clini-
cians (eligibility=those involved in the vision screening 
of patients with acute brain injury), patients (eligibili-
ty=those with brain injury causing visual impairment), 
caregivers (eligibility=those caring for people with brain 
injury causing visual impairment), editors of journals 
and COS users. Clinicians, journal editors and COS users 
were invited to participate through advertisements circu-
lated via national professional societies (eg, British and 
Irish Orthoptic Society, Royal College of Occupational 
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Therapists), via international orthoptic editorial groups 
(eg, Strabismus and British and Irish Orthoptic Journal) and 
via regional allied health profession research networks 
(Council for Allied Health Professions Research). Stroke 
survivors and caregivers were invited through advertise-
ments circulated via a national stroke/vision patient and 
public involvement panel (VISable) and through national 
charities (eg, the Stroke Association, Royal National Insti-
tute for the Blind).
Phase 1
Literature review
In order to develop a preliminary list of outcomes for a 
Delphi survey we undertook an overview of seven system-
atic reviews of studies/trials reporting vision screening, 
assessment and treatment of post-stroke visual impair-
ment.2 15–20 We extracted 119 outcomes, many of which 
were variations on test choices for specific visual func-
tions. Therefore these were combined into one outcome 
domain (table 1).
COS do not address how tests should be defined or 
measured. Thus this combination decision was made by 
the steering group who decided through discussion that 
test choice would vary on a case-by-case basis dependent 
on the patient’s ability to undertake the test and that COS 
should consider only the general assessment needed and 
not the specific methods of measurement. For example, 
logMAR, Snellen, fixation/following, grating cards and 
fixation distance were outcomes combined under one 
outcome domain of ‘visual acuity’ assessment.
This process produced a list of 22 domains for vision 
screening and a list of 24 domains for full visual assess-
ment. These lists were then circulated to the VISable 
patient and public involvement panel for approval and 
checking of writing for lay terms as the basis of the online 
survey development. VISable advised that patient-im-
portant outcomes were covered by the outcome domains 
and did not add any further outcomes to those already 
identified.
Phase 2
Delphi survey
We undertook a prospective consensus study using a 
Delphi process. Delphi is a structured process that is 
widely used in developing core outcomes sets.21 The 
process aims to achieve consensus through the collection 
of stakeholder opinions.
SurveyMonkey (SurveyMonkey, 2015) was used as the 
online platform to administer the Delphi process. The 
survey was piloted for checks of ambiguity and appro-
priate use of lay language by the steering group and then 
released live.
An email outlining the project and survey was sent out 
via stakeholder networks (as outlined earlier in the stake-
holder section) with a snowballing technique of onward 
roll-out from individual stakeholders. The Delphi survey 
consisted of three rounds (figure 1). Rounds remained 
open for 10 weeks, with regular 2-week reminders sent to 
those that had partially completed or not completed to 
maximise response rates.
In round 1, the Delphi started with an introductory 
page, which outlined the purpose of the study and how to 
complete each section, as follows:
“We are not asking you to provide detailed answers to 
these items, but to judge how important they are when 
assessing visual impairment in brain injury. Please view 
the items listed below and score their importance with 
1 being not important and 9 being critical. After a brain 
injury, patients may first have visual screening to detect if a 
visual problem is present. Once a visual problem is found, 
patients may then receive a full visual assessment. In part 
1a, please rate the items below as to how important you 
believe they are to a screening assessment. In part 1b please 
rate the items below as to how important you believe they 
are to a full visual assessment.”
All terms had explanatory notes to aid interpretation. 
All participants were asked to score each assessment in 
terms of importance and asked to identify any additional 
outcomes of importance that did not appear in the list 
of assessments. In the acknowledgement that definition 
of importance varies between individuals and between 
stakeholder groups, the Delphi survey was circulated 
widely to a variety of stakeholder groups to obtain greater 
consistency in responses. Additional outcomes added in 
round 1 were reviewed by the steering group to consider 
their relevance to the survey and to identify and remove 
duplicates.
In round 2, all data from round 1 were analysed and 
compiled by stakeholder groups; (1) stroke survivors/
carers, (2) stroke team professionals and (3) eye team 
professionals to allow different perspectives to be consid-
ered prior to re-rating.12 The summarised results for each 
stakeholder group were provided to all participants who 
fully completed the survey in the first round. Each partici-
pant was also shown their personal original score for each 
domain. Participants had the opportunity to re-score 
based on the summary scores from the three stakeholder 
groups versus their previous personal scores. All partic-
ipants were also asked to score on additional outcomes 
that were identified and added in round 1.
In round 3, the results from round 2 were analysed. 
Following analysis, the results from each stakeholder 
group were reviewed by the steering group and judged 
to be similar in terms of percentage spread across the 
responses of 1–9. Thus they were presented as one compi-
lation of all responses. Each participant was shown their 
personal score from round 2 for each domain along with 
the summary scores from all other participants, and asked 
to score each domain again in terms of importance.
Scoring method: In each round, participants were 
asked to score the importance of each domain listed 
on a 9-point scale (1–3: not important; 4–6: important 
but not critical; 7–9: critical, as well as an ‘unable to 
score’ option). The scale was devised by the Grading of 
Recommendations Assessment, Development and Evalu-
ation (GRADE) working group22 to score the quality of 
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Table 1 Outcome extraction
Screening assessment﻿‍  Out﻿‍comes ext﻿‍ract﻿‍ed from reviews   Full assessment﻿‍
Case history—open questions Case history—open questions Case history—open questions
Case history—specific questions Case history—specific questions
 ► Eye strain
 ► Reading difficulty
 ► Blurred, altered or reduced vision
 ► Visual field loss
 ► Awareness of full environment
 ► Oscillopsia
 ► Diplopia
 ► Polyopia
 ► Visual hallucinations
 ► Altered colour vision
 ► Altered movement of objects
 ► Depth perception misjudgements
 ► Tilted images
 ► Distorted images
 ► Face/object recognition
 ► Clutter difficulty
 ► Getting lost
 ► Prolongation of images
 ► Reverse image size
 ► Glare
 ► Visual crowding
 ► Visual disorientation
Case history—specific questions
Case history—carer open questions Case history—carer open questions Case history – carer open questions
Case history—carer specific questions Case history—carer specific questions
 ► Personal care issues
 ► Eyes constantly moving/jerking
 ► Missing things to one side
 ► Bumping into things
 ► Concerns over vision
 ► Visual hallucinations
 ► Family/friend recognition
 ► Difficulty naming objects
 ► Getting lost
 ► Reading problems
Case history—carer specific questions
Case history—previous ocular history Case history—previous ocular history Case history—previous ocular history
Case history—glasses wear Case history—glasses wear Case history—glasses wear
Observations—open comments Observations—open comments Observations—open comments
Observations—specific features Observations—specific features
 ► Lids
 ► Pupils
 ► Squint—misaligned eyes
 ► Eye movements
 ► Turning head to see
 ► Closing one eye to see better
 ► Misjudging distances
 ► Wobbling eyes
Observations—specific features
Visual acuity logMAR charts
Snellen charts
Fixation and following observation
Vanishing optotype charts
Grating charts
Near acuity charts
Kay’s pictures
Sheridan Gardiner single optotypes
Lea symbols
Fundus check
Retinal photography/OCT
Visual acuity
Eye alignment position Cover uncover test
Alternating cover test
Observations of corneal reflections
Eye alignment position
Continued
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Screening assessment﻿‍  Out﻿‍comes ext﻿‍ract﻿‍ed from reviews   Full assessment﻿‍
Eye movement assessment Nine positions of gaze
Horizontal gaze only
Vertical gaze only
Horizontal and vertical gaze only
Vergence
Saccade movement
Smooth pursuit movement
Optokinetic nystagmus movement
Vestibulo-ocular reflex
Hess/Lees/Harms wall charts
Eye movement assessment
Binocular vision assessment Retinal correspondence
Sensory fusion
Motor fusion
Stereopsis
Binocular vision assessment
Eye alignment measurement Prism cover test
Krimsky test
Prism reflection test
Synoptophore
Bruckner test
Maddox rod
Eye alignment measurement
Visual field assessment Confrontation
Static central perimetry
Static peripheral perimetry
Kinetic perimetry
Visual field assessment
Visual neglect assessment Line bisection
Cancellation task—star, balloon, heart, etc.
Clock drawing
Room/environment description
Behaviour inattention test battery
Visual neglect assessment
Functional assessment Observed navigation
Reading
Eye scanning
Walking observations
Activities of daily living
Self-care
Body placement
Spatial awareness
Mobility observations
Writing
Hand–eye coordination
Visual memory and cognition
Visual perception
Functional assessment
Reading assessment Special test, eg Wilkins, iReST, Radner Newspaper, 
magazine, book
Reading assessment
Questionnaires Vision-related, eg VFQ25, DLDV
Health-related, eg SF12
Activity of daily living, eg IADL
Extended activity of daily living, eg NEADL
Questionnaires
Pupil assessment Swinging flashlight test Pupil assessment
Lid assessment Palpebral apertures
Lid function test
Lid assessment
Contrast sensitivity assessment Pelli-Robson chart
Mars test
VisTech
Contrast sensitivity assessment
Colour vision assessment Ishihara test
City test
Colour vision assessment
DLDV, Daily Living tasks Dependent on Vision; IADL, Instrumental Activities of Daily Living; iReST, International Reading Speed Test; NEADL, 
Nottingham Extended Activities of Daily Living; OCT, Optical Coherence Tomography; SF12, Short Form 12; VFQ25, Visual Function Questionnaire 
25.
Table 1 Continued
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Figure 1 Flow chart of Delphi process across three survey 
rounds.
evidence for outcomes in systematic reviews and has been 
adopted in other COS development work research using 
Delphi methods.
Methods of analysis: For each round of Delphi, descrip-
tive statistics were used to summarise the results for each 
domain, including the percentage of participants scoring 
the domain at each possible response from 1 to 9.
Consensus was defined a priori; however, this informa-
tion was not provided on the Delphi survey. Participants 
were aware of these cut-off values at the time of attending 
the consensus meeting: ‘Consensus in’ (ie, consensus 
that the domain should be included in the core set) was 
defined as greater that 70% of participants scoring as 7–9 
and less than 15% of participants scoring 1–3. ‘Consensus 
out’ (ie, consensus that the domain should not be 
included in the core set) was be defined as greater than 
70% of participants scoring as 1–3 and less than 15% of 
participants scoring as 7–9. All other combinations were 
seen as equivocal. The domains that were designated as 
‘consensus in’ or seen as ‘equivocal’ were taken forward 
and discussed in more detail at the consensus meeting for 
inclusion into the final COS, one COS for screening and 
one COS for full assessment. Participants were reminded 
of all domains not reaching consensus as part of the 
Delphi process.
Phase 3
Consensus meeting
Representatives from the Delphi survey were invited 
to a face-to-face consensus meeting. All round 3 survey 
completers (n=51) were emailed an invitation. All 
stakeholders were reasonably represented. The format 
of the meeting included a short study overview, a presen-
tation containing a summary of the results and number 
of domains reaching consensus from the survey. Each 
consensus domain was considered in turn, in order of 
their presentation in the Delphi survey, to ratify these 
results. Each remaining domain was then considered, 
in turn, with full discussion. Similar to the survey, each 
domain was considered as reaching consensus with 70% 
of participants voting in favour of its inclusion.
Each participant voted on every domain being asked 
to vote ‘Yes’ (this domain should be included in the 
COS), ‘No’ (this domain should not be included) or 
‘Unsure’ using voting slips. After voting for all domains 
was completed, the results were collated during a rest 
break for the participants. When the meeting resumed, 
the results were presented to the group. Domains were 
retained or dropped when consensus was reached. 
Discussion and further rounds of voting, restricting the 
options to ‘Yes’ or ‘No’, were undertaken until consensus 
was reached on all domains. All domains retained were 
included in the final COS.
reSultS
Figure 2 outlines a flowchart of the results for number of 
participants and number of domains.
Phase 1
Outcome identification
An overview of systematic reviews produced a list of 119 
outcomes. Outcomes that were variations on test choices 
for specific visual functions were combined into outcome 
domains. This produced 22 domains for vision screening 
and a list of 24 domains for full visual assessment.
Phase 2
Delphi survey
In total 123 participants registered for round 1 of the 
Delphi survey. Six did not complete the survey. The 
remaining participants comprised 79 orthoptists, 20 occu-
pational therapists, 17 stroke survivors and 1 ophthal-
mologist. There were 20 males and 97 females with ages 
ranging from 18 to 84 years (figure 3). In round 2, 65 
participants completed the survey—an attrition of 44.5% 
from round 1. These participants comprised 47 orthop-
tists, 10 occupational therapists, 7 stroke survivors and 1 
ophthalmologist. In round 3, 51 participants completed 
the survey—an attrition of 56.4% from round 1 (78.5% 
from round 2). These participants comprised 39 ortho-
ptists, 6 occupational therapists, 5 stroke survivors and 1 
ophthalmologist.
Following completion of the survey of 46 domains 
in round 1, 12 additional outcomes were put forward 
by the participants for inclusion in round 2. These 
comprised five screening outcomes and seven full assess-
ment outcomes. After round 2 of 58 domains, three 
outcomes were excluded; these were test variations 
Protected by copyright.
 o
n
 Septem
ber 9, 2019 at University of Liverpool Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029578 on 8 September 2019. Downloaded from 
7Rowe FJ, et al. BMJ Open 2019;9:e029578. doi:10.1136/bmjopen-2019-029578
Open access
Figure 2 Flow chart of consensus process across three phases of outcome identification, Delphi survey and consensus 
meeting.
already included within the existent domains. Four 
outcomes were combined; these were variations on test 
choices and could be combined into one domain—as 
per the process outlined in phase 1. No new outcomes 
were introduced. Following round 3 of 52 domains, 
consensus was achieved for 14 screening domains leaving 
ten domains for discussion, and consensus was achieved 
for 22 full assessment domains leaving six domains for 
further discussion.
Phase 3
Consensus meeting
The consensus meeting was a 1 day event held in Liver-
pool, UK with 12 participants comprising five occupa-
tional therapists (2 with research roles), 3 orthoptists (1 
with a research role), 2 patients, 1 Cochrane editor and 1 
facilitator. The facilitator did not take part in the voting. 
The objective of the meeting was to discuss and vote on 
the Delphi domains—the results of the Delphi survey had 
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Figure 3 Age range of participants.
box 1 Core outcome sets
A Vision screening core outcome set
Vision screening COS
 ► Case history—previous ocular history and use of glasses, open 
questions
 ► Observations
 ► Visual acuity
 ► Eye alignment position
 ► Eye movement—ocular motility assessment
 ► Visual field assessment
 ► Visual neglect assessment
 ► Functional vision assessment
 ► Reading assessment
b Vision full assessment core outcome set
Full vision assessment COS
 ► Case history—previous ocular history and use of glasses, open 
questions, visual fatigue and visual perception questions
 ► Observations—including lids and pupils
 ► Visual acuity
 ► Eye alignment position
 ► Eye movement—ocular motility assessment
 ► Binocular vision assessment
 ► Eye position measurement
 ► Visual field assessment
 ► Visual neglect assessment
 ► Functional vision assessment
 ► Reading assessment
 ► Quality of life questionnaires
been provided to participants prior to and during the 
meeting.
Screening
Online supplementary table 1 shows the ranking for 
general tests considered for vision screening. The Delphi 
survey had reached the following consensus:
 ► Full consensus for inclusion was obtained for case 
history asking patients/carers open and specific ques-
tions plus checks of previous ocular history and glasses 
wear. Full consensus was obtained for observations, 
tests of visual acuity, eye alignment, eye movements, 
visual fields, visual inattention and functional visual 
assessment.
 ► Full consensus for exclusions included contrast sensi-
tivity and colour vision assessments.
 ► No consensus was reached for command saccades, 
binocular vision assessment, alignment measurement, 
reading assessment, use of questionnaires, pupil and 
lids assessment and screening for visual memory and 
recognition.
During the consensus meeting, final consensus for 
vision screening included nine domains of previous 
ocular history and glasses, case history open questions, 
observations, visual acuity, ocular alignment and eye 
movements, visual inattention, visual fields, reading 
ability and functional vision (Box 1). Experts estimated a 
vision screening assessment of no more than 20 min with 
these domains based on the use of basic screening tests of 
visual functions.
Full vision assessment
Online supplementary table 2 shows the ranking for 
general domains considered for full vision assessment. 
The Delphi survey had reached the following consensus:
 ► Full consensus for inclusion was obtained for case 
history asking patients/carers open and specific ques-
tions plus checks of previous ocular history and glasses 
wear. Full consensus for observations, tests of visual 
acuity, eye alignment, eye movements, binocular 
vision, alignment measurement, visual fields, visual 
inattention, reading, lids and pupils, visual percep-
tion and functional visual assessment.
 ► Full consensus for exclusions included retinal 
photography and OCT.
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 ► No consensus was reached for eye contact during 
conversations, use of questionnaires, contrast sensi-
tivity, colour vision and fundus checks.
During the consensus meeting, final consensus for full 
vision assessment included 12 domains of previous ocular 
history and glasses, case history open questions including 
visual fatigue and visual perception questions, obser-
vations including lids and pupils, visual acuity, ocular 
alignment and eye movements, binocular vision, visual 
inattention, visual fields, reading ability and functional 
vision, and quality of life measurement (box 1). These 
comprise detailed assessments of visual functions using 
tests validated as reliable and repeatable.
DISCuSSIOn
A COS is an agreed minimum set of outcome measures 
that should be reported. By reporting a minimum set of 
measures, this reduces the heterogeneity of outcomes 
across studies, which, in turn, supports future evidence 
synthesis.12–14 Once a COS is defined, it is important 
to achieve consensus on how the outcomes should be 
measured.23
Delphi and consensus process methods have been 
used extensively for research-oriented COS but has also 
been reported in the development of a test battery for 
visual perception screening24 and Traumatic Brain Injury 
(TBI)-related visual impairment.25 To our knowledge this is 
the first study to use these methods to develop test batteries 
for general vision screening and assessment for post-stroke 
visual impairment.
The goal of this study was to agree a COS to be used in 
the vision screening and full assessment of visual impair-
ment following stroke. After round 3 and the consensus 
meeting, stakeholders agreed with the proposed test 
battery for vision screening consisting of 9 domains and 
for full vision assessment consisting of 11 domains. The 
vision screening COS is intended for clinicians who have 
no formal training or experience in providing eye tests. 
However, it is acknowledged by expert consensus that the 
specific sections of visual inattention and functional vision 
assessments are key areas where assessments by members 
of the stroke team (eg, by occupational therapists) do not 
require formal eye training. The full vision assessment 
COS is intended for specialist vision assessment by profes-
sions such as orthoptists and ophthalmologists. Of impor-
tance, these COS are the core identified assessments to be 
made wherever possible when screening or fully assessing 
the visual functions of stroke survivors. These COS do 
not exclude further visual assessments which should be 
added as appropriate and relevant for the individual 
stroke survivor. Equally, some COS measures may not be 
achievable due to patient cognitive, communication and 
physical impairments which prevent assessment.
There are a number of strengths for this study. Two 
COS have been produced, one for vision screening and 
one for full vision assessment which addresses a gap in 
evidence-based practice for post-stroke visual impairment. 
Each COS is composed of domains which were ranked 
by Delphi and consensus opinion from multidisciplinary 
experts and stroke survivors. As these COS are derived 
from clinical and research stakeholders, and patients 
and carers, they are potentially suitable for research in 
addition to clinical practice. Furthermore they are based 
on existent outcomes that are easily accessible for imple-
mentation, and accepted as validated clinical measures. 
Although these COS were developed for stroke, there is 
potential for their use with other types of acquired brain 
injury causing visual impairment.
There are limitations to this study. Participants were 
from UK and Ireland and largely represented views and 
practices within the NHS. Thus, assessments are those 
used clinically in these countries. It would be valuable 
to seek expert opinion from international participants 
regarding the key assessments and their specific outcome 
measures. However, we recognise that the assessment 
domains selected for the COS are those that are widely 
used internationally in clinical and research settings as 
evidenced from our initial literature review.2 19 21 We had 
a limited response by ophthalmologists in the Delphi 
process, with none subsequently involved in the consensus 
meeting. However, within the UK and Ireland, orthoptists 
are the clinical professionals predominantly responsible 
for the diagnosis and management of stroke-related visual 
impairment. Thus the greater response from orthoptists 
in the Delphi survey and consensus process was expected 
and, we believe, provided robust information required 
for this study. In other countries, decisions should be 
taken as to whether involvement of other clinical profes-
sionals in the care of these patients would alter the COS 
lists. We also experienced attrition bias across the Delphi 
rounds. The attrition rate at round 2 was 44.5% and, by 
round 3, was 56.4% from the initial sample. High attrition 
rates however are common using Delphi methods and 
our rates can be considered within an acceptable range 
based on those reported for other COS developments.26 
Nevertheless a larger sample would have been preferable. 
Researcher bias is also a potential limitation. We aimed 
to limit this by providing a summary of results across all 
rounds of the Delphi survey and with final decisions left 
to the consensus meeting with experts. There can be risks 
from using Delphi methods in which participants can have 
very disparate views of each outcome. However, we sought 
a wide variety of participants across a number of stake-
holder groups to achieve greater consistency in responses 
and balance potential outlier responses. Further, this 
core outcome development process included a final stage 
of consensus meeting such that decisions were not purely 
made from the Delphi responses.
COnCluSIOnS
This study reports the use of Delphi and consensus 
methods in the development of COS for vision screening 
and full vision assessment of stroke survivors. Vision 
screening comprises 9 assessment domains and full vision 
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assessment comprises 11 domains. These COS will facili-
tate standardisation of screening and assessment of post-
stroke visual impairment while also having the potential 
to reduce heterogeneity in assessment in future research. 
Further research is now required to evaluate the use of 
these COS and outcome measures.
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